Evaluation and review of preventive measures applied during COVID-19 pandemic: strategies adopted by European countries
pdf

Keywords

SARS-CoV-2
COVID-19
Public Health
Preventive Measures
Health Communication
Health Governance
National Health Policies

Abstract

The COVID-19 pandemic has greatly jeopardized the European continent and the spread of SARS-COV-2 has led European countries to implement a series of preventive interventions aimed at decreasing the incidence rate of the disease, in consideration of the lack of specific therapies and of a vaccine. Each European country has behaved in different ways and timing accordingly to the epidemiological trend and to different political strategies. The main purpose of preventive measures is to lower the incidence rate of the disease, avoiding the collapse of health systems and limiting the total number of severe cases and deaths. All these targets should fit with needs that go beyond scientific evidence such as economic interests, decisions of neighboring countries and specific socio-political factors for each country. The objective of this research is to clarify which preventive measures have been recommended and applied in different European countries.

https://doi.org/10.15167/2421-4248/jpmh2021.62.1s3.1851
pdf

References

[1] ECDC, “Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK – tenth update,” 2020. [Online]. Available: https://www.ecdc.europa.eu/sites/default/files/documents/RRA-COVID19-update10-2020-06-11.pdf. [Accessed: 15-Jun-2020].
[2] G. Gabutti, E. D’Anchera, F. Sandri, M. Savio, and A. Stefanati, “Coronavirus: Update Related to the Current Outbreak of COVID-19,” Infect. Dis. Ther., vol. 9, no. 2, pp. 241–253, Jun. 2020, doi: 10.1007/s40121-020-00295-5.
[3] ECDC, “COVID-19 pandemic.” [Online]. Available: https://www.ecdc.europa.eu/en/covid-19-pandemic. [Accessed: 09-Oct-2020].
[4] WHO, “Coronavirus disease (COVID-19) Global epidemiological situation.” [Online]. Available: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20201005-weekly-epi-update-8.pdf. [Accessed: 09-Oct-2020].
[5] Istituto Superiore di Sanità, “Indicazioni ad interim per la sanificazione degli ambienti interni nel contesto sanitario e assistenziale per prevenire la trasmissione di SARS-CoV 2,” Roma, 2020.
[6] WHO, “Transmission of SARS-CoV-2: implications for infection prevention precautions.” [Online]. Available: https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions. [Accessed: 30-Jul-2020].
[7] Istituto Superiore di Sanità, “Raccomandazioni per la disinfezione di ambienti esterni e superfici stradali per la prevenzione della trasmissione dell’infezione da SARS-CoV-2,” Roma, 2020.
[8] Istituto Superiore di Sanità, “Indicazioni sugli impianti di ventilazione/climatizzazione in strutture comunitarie non sanitarie e in ambienti domestici in relazione alla diffusione del virus SARS-CoV-2,” Roma, 2020.
[9] L. Morawska and D. K. Milton, “It is Time to Address Airborne Transmission of COVID-19,” Clin. Infect. Dis., Jul. 2020, doi: 10.1093/cid/ciaa939.
[10] Istituto Superiore di Sanità, “Raccomandazioni ad interim sulla sanificazione di strutture non sanitarie nell’attuale emergenza COVID-19: superfici, ambienti interni e abbigliamento,” Roma, 2020.
[11] ECDC, “Considerations relating to social distancing measures in response to COVID-19 – second update,” 2020. [Online]. Available: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-social-distancing-measuresg-guide-second-update.pdf. [Accessed: 29-May-2020].
[12] WHO, “Advice for the public.” [Online]. Available: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public. [Accessed: 30-Jul-2020].
[13] Istituto Superiore di Sanità, “Indicazioni ad interim per la prevenzione e il controllo dell’infezione da SARS-COV-2 in strutture residenziali sociosanitarie,” Roma, 2020.
[14] Istituto Superiore di Sanità, “Indicazioni ad interim per la prevenzione e gestione degli ambienti indoor in relazione alla trasmissione dell’infezione da virus SARS-CoV-2,” Roma, 2020.
[15] ECDC, “Guidance for discharge and ending isolation in the context of widespread community transmission of COVID-19-first update Scope of this document,” 2020. [Online]. Available: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-guidance-discharge-and-ending-isolation-first update.pdf. [Accessed: 30-Jul-2020].
[16] WHO The Health System Response Monitor, “Search and Compare - HSRM.” [Online]. Available: https://www.covid19healthsystem.org/searchandcompare.aspx. [Accessed: 09-Jul-2020].
[17] ECDC, “Leaflet: information on self-isolation and quarantine after exposure to COVID-19.” [Online]. Available: https://www.ecdc.europa.eu/en/publications-data/leaflet-information-self-isolation-and-quarantine-after-exposure-covid-19. [Accessed: 30-Jul-2020].
[18] ECDC, “Case definition for coronavirus disease 2019 (COVID-19), as of 29 May 2020.” [Online]. Available: https://www.ecdc.europa.eu/en/covid-19/surveillance/case-definition. [Accessed: 30-Jul-2020].
[19] K. N. Vokinger, V. Nittas, C. M. Witt, S. I. Fabrikant, and V. von Wyl, “Digital health and the COVID-19 epidemic: an assessment framework for apps from an epidemiological and legal perspective,” Swiss Med. Wkly., vol. 150, no. May, p. w20282, 2020, doi: 10.4414/smw.2020.20282.
[20] A. Donzelli, “Mascherine ‘chirurgiche’ in comunità/all’aperto: prove di efficacia e sicurezza inadeguate - E&P Repository.” [Online]. Available: https://repo.epiprev.it/index.php/2020/05/12/mascherine-chirurgiche-in-comunita-allaperto-prove-di-efficacia-e-sicurezza-inadeguate/. [Accessed: 09-Oct-2020].
[21] P. M. Matricardi, R. W. Dal Negro, and R. Nisini, “The first, holistic immunological model of COVID‐19: Implications for prevention, diagnosis, and public health measures,” Pediatr. Allergy Immunol., vol. 31, no. 5, pp. 454–470, Jul. 2020, doi: 10.1111/pai.13271.
[22] Z. Střížová, J. Bartůňková, and D. Smrž, “Can wearing face masks in public affect transmission route and viral load in COVID-19?,” Cent. Eur. J. Public Health, vol. 28, no. 2, pp. 161–162, 2020, doi: 10.21101/cejph.a6290.
[23] C. R. MacIntyre and A. A. Chughtai, “A rapid systematic review of the efficacy of face masks and respirators against coronaviruses and other respiratory transmissible viruses for the community, healthcare workers and sick patients,” Int. J. Nurs. Stud., vol. 108, Aug. 2020, doi: 10.1016/j.ijnurstu.2020.103629.
[24] A. I. Lazzarino, “Covid-19: Important potential side effects of wearing face masks that we should bear in mind,” doi: 10.1136/bmj.m1435.
[25] WHO The Health System Response Monitor, “What channels are countries using to communicate with the public and at what frequency? – Cross-Country Analysis.” [Online]. Available: https://analysis.covid19healthsystem.org/index.php/2020/07/03/what-channels-are-countries-using-to-communicate-with-the-public-and-at-what-frequency/. [Accessed: 09-Jul-2020].
[26] WHO, “COVID-19 advice - Know the facts | WHO Western Pacific.” [Online]. Available: https://www.who.int/westernpacific/emergencies/covid-19/information/physical-distancing. [Accessed: 21-Jul-2020].
[27] WHO The Health System Response Monitor, “What are the policies on wearing facemasks in public places? – Cross-Country Analysis.” [Online]. Available: https://analysis.covid19healthsystem.org/index.php/2020/05/22/what-are-the-policies-on-wearing-facemasks-in-public-places/. [Accessed: 09-Jul-2020].
[28] ECDC, “Guidelines for the use of non-pharmaceutical measures to delay and mitigate the impact of 2019-nCoV,” 2020. [Online]. Available: https://www.ecdc.europa.eu/sites/default/files/documents/novel-coronavirus-guidelines-non-pharmaceutical-measures_0.pdf. [Accessed: 03-Jun-2020].
[29] European Commission, “Joint European Roadmap towards lifting COVID-19 containment measures.” [Online]. Available: https://www.clustercollaboration.eu/news/joint-european-roadmap-towards-lifting-covid-19-containment-measures. [Accessed: 15-Jun-2020].
[30] ERA and ECDC, “COVID-19 Rail Protocol Recommendations for safe resumption of railway services,” no. July, pp. 1–19, 2020.
[31] WHO The Health System Response Monitor, “How do countries control the entry of travellers during the COVID-19 pandemic? – Cross-Country Analysis.” [Online]. Available: https://analysis.covid19healthsystem.org/index.php/2020/06/03/how-do-countries-control-the-entry-of-travellers-during-the-covid-19-pandemic/. [Accessed: 09-Jul-2020].
[32] ECDC, “Weekly COVID-19 country overview.” [Online]. Available: https://www.ecdc.europa.eu/en/covid-19/country-overviews. [Accessed: 27-Jul-2020].